Q1 2026 Holdings
Filed 2026-05-15 | 22 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $339.1M | 6,897,652 | 32.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $159.0M | 5,871,018 | 15.5% |
| Alumis Inc(ALMS) | COM | 022307102 | $139.8M | 6,345,219 | 13.6% |
| Septerna Inc(SEPN) | COM | 81734D104 | $75.7M | 3,149,128 | 7.4% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $74.7M | 12,948,081 | 7.3% |
| Spyglass Pharma Inc(SGP) | COM SHS | 85220G109 | $54.7M | 2,109,953 | 5.3% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $34.6M | 1,717,127 | 3.4% |
| Inventiva SA(IVA) | ADS | 46124U107 | $28.8M | 5,194,805 | 2.8% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $26.5M | 1,062,872 | 2.6% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $13.6M | 968,798 | 1.3% |
| VTV Therapeutics Inc(VTVT) | CL A NEW | 918385204 | $11.8M | 298,496 | 1.2% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $10.4M | 2,500,000 | 1.0% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $7.6M | 1,832,566 | 0.7% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $7.4M | 3,507,666 | 0.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $7.0M | 60,873 | 0.7% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $6.6M | 736,047 | 0.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $6.3M | 56,581 | 0.6% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $6.3M | 600,000 | 0.6% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $6.2M | 8,500,000 | 0.6% |
| Coherus Oncology Inc(CHRS) | COM | 19249H103 | $5.8M | 3,428,571 | 0.6% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $4.8M | 38,432 | 0.5% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $2.4M | 7,222,559 | 0.2% |